Quanterix Corp
For the period ended Dec 31, 2025. Filed Mar 2, 2026.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2025 · Filed Mar 2, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Signatures
Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
| Date: March 2, 2026 | By: | /s/ EVERETT CUNNINGHAM |
|---|---|---|
| Everett Cunningham | ||
| President and Chief Executive Officer | ||
Pursuant to the requirements of the Securities Exchange Act of 1934, this report has been signed below by the following persons on behalf of the registrant and in the capacities and on the dates indicated.
| Signature | Title | Date |
|---|---|---|
| /s/ EVERETT CUNNINGHAM | President and Chief Executive Officer and Director (Principal Executive Officer) | March 2, 2026 |
| Everett Cunningham | ||
| /s/ VANDANA SRIRAM | Chief Financial Officer (Principal Financial Officer and Principal Accounting Officer) | March 2, 2026 |
| Vandana Sriram | ||
| /s/ WILLIAM DONNELLY | Director and Chairman of the Board | March 2, 2026 |
| William Donnelly | ||
| /s/ JEFFREY T. ELLIOTT | Lead Independent Director | March 2, 2026 |
| Jeffrey T. Elliott | ||
| /s/ KAREN A. FLYNN | Director | March 2, 2026 |
| Karen A. Flynn | ||
| /s/ GARRET HAMPTON, Ph.D. | Director | March 2, 2026 |
| Garret Hampton, Ph.D. | ||
| /s/ MYLA LAI-GOLDMAN M.D. | Director | March 2, 2026 |
| Myla Lai-Goldman M.D. | ||
| /s/ IVANA MAGOVČEVIĆ-LIEBISCH, PH.D., J.D. | Director | March 2, 2026 |
| Ivana Magovčević-Liebisch, Ph.D., J.D. | ||
| /s/ SCOTT MENDEL | Director | March 2, 2026 |
| Scott Mendel | ||
| /s/ ALAN SACHS, M.D., Ph.D. | Director | March 2, 2026 |
| Alan Sachs, M.D., Ph.D. | ||
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.